< 2% of new compounds investigated may show suitable biological activityModification of an existing drug can yield as little as 1% suitable compounds< 10% of these compounds result in successful human clinical trials and reaches the market place
Health insurance portability n accountabilityProduct devolp n management associatnCentral drug stndrd controlorganisation